Sutton Wealth Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-52
Closed -$773 1245
2022
Q4
$773 Buy
52
+46
+767% +$751 ﹤0.01% 1404
2022
Q3
$99 Sell
6
-411
-99% -$8.27K ﹤0.01% 1600
2022
Q2
$8.76K Buy
+417
New +$8.51K ﹤0.01% 943
2022
Q1
Sell
-950
Closed -$25.9K 1677
2021
Q4
$25.9K Sell
950
-65
-6% -$1.74K 0.01% 633
2021
Q3
$28.9K Buy
1,015
+211
+26% +$6.43K 0.01% 575
2021
Q2
$24.2K Sell
804
-1
-0.1% -$30 0.01% 647
2021
Q1
$20.5K Buy
+805
New +$20.6K 0.01% 668
2020
Q1
Sell
-2,182
Closed -$60.6K 1239
2019
Q4
$60.6K Hold
2,182
0.03% 274
2019
Q3
$49.4K Hold
2,182
0.03% 311
2019
Q2
$55.1K Hold
2,182
0.03% 281
2019
Q1
$59.3K Hold
2,182
0.03% 260
2018
Q4
$72K Hold
2,182
0.05% 233
2018
Q3
$102K Hold
2,182
0.07% 196
2018
Q2
$94.4K Hold
2,182
0.07% 205
2018
Q1
$121K Hold
2,182
0.09% 177
2017
Q4
$117K Hold
2,182
0.09% 184
2017
Q3
$94.1K Hold
2,182
0.07% 198
2017
Q2
$132K Hold
2,182
0.1% 169
2017
Q1
$151K Hold
2,182
0.13% 140
2016
Q4
$145K Hold
2,182
0.13% 139
2016
Q3
$145K Hold
2,182
0.13% 132
2016
Q2
$158K Hold
2,182
0.15% 116
2016
Q1
$141K Buy
+2,182
New +$145K 0.13% 135

Other funds holding MD

Sutton Wealth Advisors's MD Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 52 shares — an estimated $773 sold.

Sutton Wealth Advisors first reported a position in MD in Q1 2016 and held it in 23 quarters. The position peaked at $158K in Q2 2016. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 52 Pediatrix Medical shares in Q1 2023, an estimated $773.
  • Sutton Wealth Advisors first reported a position in Pediatrix Medical in Q1 2016 and held it in 23 quarters.
  • Sutton Wealth Advisors's Pediatrix Medical position peaked at $158K in Q2 2016.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.